Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.60
Bid: 76.90
Ask: 78.40
Change: -0.60 (-0.78%)
Spread: 1.50 (1.951%)
Open: 76.60
High: 76.60
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results - Placing, Open Offer & C Share Offer

13 Mar 2014 11:40

RNS Number : 2367C
GCP Infrastructure Investments Ltd
13 March 2014
 



NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

 

This announcement is not a prospectus. This announcement does not constitute or form part of, and should not be construed as, any offer or invitation to sell, issue, purchase or subscribe for, or any solicitation of any offer to sell, issue, purchase or subscribe for, any shares in the Company or securities in any other entity nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision in relation thereto. This announcement does not constitute a recommendation regarding any securities.

 

 

GCP Infrastructure Investments Limited (the "Company")

 

Result of Placing, Open Offer and Offer for Subscription of C Shares

 

13 March 2014

 

On 20 January 2014, the Company announced its intention to raise additional capital through a Placing, Open Offer and Offer for Subscription of C Shares of £0.01 each (the "C Shares") at an issue price of £1.00 per C Share (the "Issue") and the creation of a placing programme in relation to its Ordinary Shares of £0.01 each (the "Ordinary Shares") (the "Placing Programme"). 

 

The Company is pleased to announce today that the Issue has been significantly oversubscribed. Taking into account the lending opportunities available for investment in the near term, the Company will accept gross proceeds under the Issue of £80 million.

 

As the Issue was considerably oversubscribed, applications under the Issue will be scaled back in accordance with the terms and conditions set out in the Prospectus; however all applications made pursuant to Basic Entitlements under the Open Offer will be met in full.

 

A total of 80,000,000 C Shares will be issued (subject to Admission), of which 50,682,580 C Shares will be issued pursuant to the Open Offer and 29,317,420 C Shares will be issued pursuant to the Placing and the Offer for Subscription.

 

Application has been made for the C Shares to be admitted to the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). It is expected that Admission will become effective and dealings in the C Shares will commence on 18 March 2014.

 

Commenting on the fundraising, Ian Reeves CBE, Chairman, said:

"We are delighted with the support demonstrated by both existing shareholders and new investors for this equity raise. The strong demand for shares is a pleasing endorsement of our success in delivering the Company's investment objective to provide shareholders with regular, sustainable, long-term distributions and to preserve the capital value of its investment assets over the long term. The Board remains focused on this objective and as a result, the proceeds raised have been capped at £80 million in order to execute the specifically identified investment opportunities available to the Company in the near future."

Following Admission, the Company expects to have 355,058,164 Ordinary Shares and 80,000,000 C Shares in issue. The International Security Identification Number for the C Shares is JE00BJT12C24 and the TIDM is GCPI. The total number of voting rights of the Company will be 435,058,164 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company.

 

 

Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

Rollo Wright

 

 

+44 (0)20 7518 1495

+44 (0)20 7518 1493

Oriel Securities

Mark Bloomfield

Tunga Chigovanyika

Neil Winward

 

+44 (0)20 7710 7600

Cenkos Securities

Dion Di Miceli

Tom Scrivens

 

+44 (0)20 7397 1921

+44 (0)20 7397 1915

Buchanan

Charles Ryland

Sophie McNulty

 

 

+44 (0)20 7466 5000

Words and expressions that are defined in the prospectus published on 12 February 2014 by the Company shall have the same meanings where they are used in this announcement, except where the context requires otherwise.

 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa. The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act" or the US Investment Company Act of 1940, as amended) and may not be offered or sold directly or indirectly into the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQKNDQDBKDKND
Date   Source Headline
10th Jul 20177:00 amRNSPlacing under Placing Programme
6th Jun 20173:31 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:18 amRNSDirector/PDMR Shareholding
2nd Jun 201711:18 amRNSTotal Voting Rights
25th May 20177:00 amRNSHalf-yearly report and financial statements 2017
24th May 201710:51 amRNSAdditional Listing
8th May 20174:52 pmRNSSCRIP Dividend Circular
2nd May 201710:22 amRNSInvestor Report - 31 March 2017
2nd May 20179:26 amRNSInvestor Report - 31 March 2017
26th Apr 20172:35 pmRNSAdditional investment commitment of up to £40.0m
20th Apr 201712:57 pmRNSDividend Declaration & Scrip Dividend Alternative
20th Apr 201710:18 amRNSConditional investment commitment
20th Apr 20178:11 amRNSNovation of investment advisory agreement
10th Apr 20173:52 pmRNSNet Asset Value(s)
28th Mar 20174:21 pmRNSPublication of a Prospectus
8th Mar 20172:39 pmRNSDirector/PDMR Shareholding
3rd Mar 201710:26 amRNSDirector/PDMR Shareholding
3rd Mar 201710:24 amRNSTotal Voting Rights
21st Feb 201710:45 amRNSAdditional Listing
13th Feb 20174:58 pmRNSReplacement: Result of AGM
10th Feb 20173:57 pmRNSResult of EGM
10th Feb 20173:54 pmRNSResult of AGM
3rd Feb 20174:56 pmRNSSCRIP Dividend Circular
30th Jan 20171:26 pmRNSInvestor Report - 31 December 2016
18th Jan 20173:44 pmRNSRevolving Credit Facility
17th Jan 20175:31 pmRNSNew Directorship Notification
17th Jan 20172:11 pmRNSDividend Declaration
10th Jan 20177:00 amRNSNet Asset Value(s)
5th Jan 20174:59 pmRNSNotice of AGM & EGM
14th Dec 20163:03 pmRNSNotification of Major Interest in Shares
14th Dec 201611:38 amRNSReplacement Annual Financial Report
14th Dec 20167:15 amRNSPublication of Supplementary Prospectus
14th Dec 20167:00 amRNSAnnual Report and Financial Statements
9th Dec 20164:53 pmRNSDirector/PDMR Shareholding
1st Dec 20169:47 amRNSTotal Voting Rights
29th Nov 20163:29 pmRNSNotification of Major Interest in Shares
29th Nov 20169:56 amRNSResult of Placing and Additional Listing
18th Nov 20167:00 amRNSPlacing under the Placing Programme
15th Nov 20163:08 pmRNSAdditional Listing and Total Voting Rights
1st Nov 20167:00 amRNSScrip Dividend Circular
14th Oct 20161:19 pmRNSReplacement Dividend Declaration & Scrip Dividend
14th Oct 20169:27 amRNSDividend Declaration
13th Oct 20164:13 pmRNSInvestor Report - 30 September 2016
10th Oct 20167:00 amRNSInvestment commitment of up to c.£60.0 million
7th Oct 20165:24 pmRNSNet Asset Value(s)
30th Aug 201610:55 amRNSTotal Voting Rights
17th Aug 20165:19 pmRNSAdditional Listing
1st Aug 20165:00 pmRNSScrip Dividend Circular
29th Jul 201612:00 pmRNSTotal Voting Rights
26th Jul 20164:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.